| Financial Year |
March 31 2023 |
| Monetary Funds |
8,033,392,916.74 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,589,281,230.76 |
| Accounts Receivable |
2,198,067,346.00 |
| Advances to Suppliers |
3,429,036,541.02 |
| Other Receivables |
647,116,341.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
7,654,000.00 |
| Inventories |
4,053,709,702.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
13,020,328.82 |
| Other Current Assets |
589,168,075.10 |
| Total Current Assets |
25,402,690,765.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
480,351,210.65 |
| Long-term Equity Investment |
3,024,701,686.43 |
| Investment Properties |
207,563,675.14 |
| Fixed Assetes |
35,887,056,680.95 |
| Under-construction Projects |
10,277,508,720.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,674,735,356.61 |
| R&D expenses |
-- |
| Goodwill |
60,463,503.56 |
| Long-Term Deferred and Prepaid Expenses |
464,704,235.74 |
| Deferred Income Tax Assets |
223,374,544.37 |
| Other Non-Current Assets |
1,413,720,258.28 |
| Sub-Total of Non-Current Assets |
56,798,493,053.88 |
| Total Assets |
82,201,183,819.62 |
| Short-Term Loans |
7,207,425,636.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,116,493,263.81 |
| Accounts Payable |
6,461,429,101.11 |
| Accounts Received In Advance |
1,332,777.64 |
| Employee Compensation Payable |
220,699,112.02 |
| Taxes Payable |
381,778,744.18 |
| Interest Payable |
-- |
| Dividend Payable |
10,290,000.00 |
| Other payables |
344,805,368.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,419,536,454.02 |
| Other Current Liabilities |
7,100,518,501.75 |
| Sub-Total of Current Liabilities |
33,788,735,593.36 |
| Long-term Loans |
7,955,513,073.23 |
| Bonds Payable |
2,062,462,703.02 |
| Long-Term Accounts Payable |
5,267,966,492.12 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
24,832,750.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,927,152,053.43 |
| Total Liabilities |
49,715,887,646.79 |
| Paid-In Capital(Or Share Stock) |
2,600,819,517.00 |
| Capital Surplus |
12,737,598,013.03 |
| Surplus Reserve |
1,107,737,736.58 |
| LESS:Treasury Stock |
133,927,200.00 |
| Undistributed Profits |
9,052,928,913.30 |
| Minority Stockholder's Interest |
7,069,761,795.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
25,415,534,377.13 |
| Owner's Equity（Stockholder's Equity） |
32,485,296,172.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
82,201,183,819.62 |
